159 related articles for article (PubMed ID: 20927020)
1. PET/CT and radiotherapy in gynecological cancer.
Caroli P; Fanti S
Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):533-42. PubMed ID: 20927020
[TBL] [Abstract][Full Text] [Related]
2. The role of PET/CT scanning in radiotherapy planning.
Jarritt PH; Carson KJ; Hounsell AR; Visvikis D
Br J Radiol; 2006 Sep; 79 Spec No 1():S27-35. PubMed ID: 16980683
[TBL] [Abstract][Full Text] [Related]
3. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
[TBL] [Abstract][Full Text] [Related]
4. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
[TBL] [Abstract][Full Text] [Related]
5. Variation in radiotherapy target volume definition, dose to organs at risk and clinical target volumes using anatomic (computed tomography) versus combined anatomic and molecular imaging (positron emission tomography/computed tomography): intensity-modulated radiotherapy delivered using a tomotherapy Hi Art machine: final results of the VortigERN study.
Chatterjee S; Frew J; Mott J; McCallum H; Stevenson P; Maxwell R; Wilsdon J; Kelly CG
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e173-9. PubMed ID: 23079100
[TBL] [Abstract][Full Text] [Related]
6. FDG PET/CT in monitoring response to treatment in gynecological malignancies.
Amit A; Person O; Keidar Z
Curr Opin Obstet Gynecol; 2013 Feb; 25(1):17-22. PubMed ID: 23299090
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography in gynecologic cancer.
Yen TC; Lai CH
Semin Nucl Med; 2006 Jan; 36(1):93-104. PubMed ID: 16356798
[TBL] [Abstract][Full Text] [Related]
8. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the Use of 18F-FDG PET CT for External Beam Radiotherapy Planning in Gynaecological Malignancies.
Kerr A; Reed N; Harrand R; Graham K; Sadozye AH
Curr Oncol Rep; 2018 Sep; 20(10):84. PubMed ID: 30206712
[TBL] [Abstract][Full Text] [Related]
10. Gynecologic oncologic imaging with PET/CT.
Grant P; Sakellis C; Jacene HA
Semin Nucl Med; 2014; 44(6):461-78. PubMed ID: 25362236
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography-computed tomography imaging for malignancies in women.
Viswanathan C; Bhosale PR; Shah SN; Vikram R
Radiol Clin North Am; 2013 Nov; 51(6):1111-25. PubMed ID: 24210447
[TBL] [Abstract][Full Text] [Related]
12. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
13. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma.
Moureau-Zabotto L; Touboul E; Lerouge D; Deniaud-Alexandre E; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Kerrou K; Montravers F; Keraudy K; Tiret E; Gendre JP; Grange JD; Houry S; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):340-5. PubMed ID: 16168829
[TBL] [Abstract][Full Text] [Related]
14. The Role of PET Imaging in Gynecologic Radiation Oncology.
Rao YJ; Grigsby PW
PET Clin; 2018 Apr; 13(2):225-237. PubMed ID: 29482751
[TBL] [Abstract][Full Text] [Related]
15. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries.
Schwarz JK; Grigsby PW; Dehdashti F; Delbeke D
J Nucl Med; 2009 May; 50 Suppl 1():64S-73S. PubMed ID: 19380409
[TBL] [Abstract][Full Text] [Related]
16. Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer.
Guido A; Fuccio L; Rombi B; Castellucci P; Cecconi A; Bunkheila F; Fuccio C; Spezi E; Angelini AL; Barbieri E
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):759-63. PubMed ID: 18834671
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer.
Vinod SK; Kumar S; Holloway LC; Shafiq J
J Med Imaging Radiat Oncol; 2010 Apr; 54(2):152-60. PubMed ID: 20518880
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer.
Bassi MC; Turri L; Sacchetti G; Loi G; Cannillo B; La Mattina P; Brambilla M; Inglese E; Krengli M
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1423-6. PubMed ID: 17931795
[TBL] [Abstract][Full Text] [Related]
19. [¹⁸F]fluorodeoxyglucose PET/computed tomography in breast cancer and gynecologic cancers: a literature review.
Hildebrandt MG; Kodahl AR; Teilmann-Jørgensen D; Mogensen O; Jensen PT
PET Clin; 2015 Jan; 10(1):89-104. PubMed ID: 25455882
[TBL] [Abstract][Full Text] [Related]
20. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D
Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
